Ray Sumita — SEC Form 4 filings
SEC reporting owner CIK 1579629. 6 Form 4 filings on record with FilingPulse; latest filed 2026-08-17.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-04-29 to 2026-08-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 3 legs across 1 filing — 8,829 shares, $265,628 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 8.
- Largest priced transaction: sale of 6,442 shares @ $30.35 ($195,515) in Cue Biopharma, Inc., filed 2026-08-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | Chief Legal Compliance Officer | 2 | — | 3 legs · 8,829 sh · $265,628 | 4 |
| Biomea Fusion, Inc. (BMEA) | Director | 3 | — | — | 3 |
| Vaxxinity, Inc. (VAXX) | Chief Legal, Comp & Admin Off | 1 | — | — | 1 |
Form 4 filings — Ray Sumita
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-17 | 4 | Cue Biopharma, Inc. (CUE) | Option exercise (M): 18,196 @ $0 · Sale (S): 2,383 @ $29.37 · Sale (S): 6,442 @ $30.35 · Sale (S): 4 @ $31.13 · Option exercise (M): 18,196 (derivative) @ $0 | EDGAR |
| 2026-07-10 | 4 | Cue Biopharma, Inc. (CUE) | Grant/award (A): 54,589 @ $0 · Grant/award (A): 54,589 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Biomea Fusion, Inc. (BMEA) | Grant/award (A): 196,299 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | Biomea Fusion, Inc. (BMEA) | Grant/award (A): 91,970 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | Biomea Fusion, Inc. (BMEA) | Grant/award (A): 51,025 (derivative) @ $0 | EDGAR |
| 2024-04-29 | 4 | Vaxxinity, Inc. (VAXX) | Grant/award (A): 425,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1579629 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →